AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Vaccine Against Group A Strep Infections Approved For Phase I/II Clinical Trial.(Brief Article)
2001 APR 11 - (NewsRx.com & NewsRx.net) --
ID Biomedical Corp. announced on March 21, 2001, that it has been granted permission by the Therapeutic Products Program of Health Canada to conduct a Phase I/II clinical trial of StreptAvax(TM), a vaccine for the prevention of infections caused by group A Streptococcus.
StreptAvax is the only vaccine of its kind being tested in human clinical trials. It is a multivalent recombinant vaccine developed to cover 26 serotypes of group A Streptococcus. According to data obtained from the U.S. Centers for Disease Control and Prevention (CDC), these serotypes are believed to be responsible for causing the vast majority of group A Streptococcus-related diseases.
The proposed clinical trial will initially evaluate the safety of StreptAvax in a small group of adults. With positive results, the studies will move to examine the safety and immune response of the vaccine in children. In this portion of the clinical trial, ID Biomedical expects children of two different age groups to receive StreptAvax: adolescents, age 10 to 14 years of age, and the target age group for which StreptAvax is being primarily developed: preschool ...
- ID Biomedical initiates Streptavax(TM) Clinical Trial.
- Press release article from: PR Newswire July 24, 2001 700+ words
...PRNewswire/ - ID Biomedical Corporation today...started a Phase I/II Clinical Trial of StreptAvax...clinical trials. The clinical trial will initially evaluate...this portion of the clinical trial, ID Biomedical expects children...
- ID Biomedical announces positive results from FluINsure(TM) clinical trial.
- Press release article from: PR Newswire April 2, 2002 700+ words
...FirstCall/ - ID Biomedical Corporation announced...Company's Phase I Clinical Trial of FluINsure...with FluINsure, ID Biomedical's non- living...from the Phase I Clinical Trial will be presented by ID Biomedical's Chief Scientific...
- ID Biomedical announces positive results from StreptAvax(TM) clinical trial;...
- Press release article from: PR Newswire March 20, 2002 700+ words
...FirstCall/ - ID Biomedical Corporation...s Phase I Clinical Trial of StreptAvax...presentation of these clinical trial results. Anthony...M.D., ID Biomedical's Chief Executive...toxicities. These clinical trial results v
- ID Biomedical announces clinical trial of StreptAvax(TM) fully enrolled.
- Press release article from: PR Newswire September 24, 2001 700+ words
...24 /PRNewswire/ - ID Biomedical announced today that...TM). StreptAvax, ID Biomedical's vaccine for the...testing. The current clinical trial is evaluating the safety...vaccine in children. ID Biomedical expects to enroll children...
- ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral...
- Press release article from: PR Newswire March 30, 2005 700+ words
...Holler, M.D., ID Biomedical's Chief Executive Officer. ID Biomedical is also conducting a similar clinical trial of Fluviral in Canada...review mechanisms. ID Biomedical and CBER have outlined a clinical trial program that will...
- ID Biomedical Announces Positive Preliminary Results From Clinical Trial of...
- Press release article from: PR Newswire January 7, 1999 700+ words
...PRNewswire/ -- ID Biomedical Corporation (IDB...preliminary results of the clinical trial of its rapid culture...308 samples tested. ID Biomedical President, Dr. Tony...Dr. Robert Bryan, ID Biomedical's Vice President...
- ID Biomedical Announces Positive Results from Phase II Clinical Trial of...
- Press release article from: PR Newswire August 10, 2004 700+ words
...expanded Phase II Clinical Trial. - Key supportive...TSX - "IDB" ID Biomedical announced today...subject in the clinical trial has developed...will be used by ID Biomedical to approach...of the human clinical trial data of StreptAvax...
- ID Biomedical announces positive results from Phase II clinical trial of...
- News wire article from: Asia Africa Intelligence Wire August 10, 2004 700+ words
...Press Release) ID Biomedical announced the completion...No subject in the clinical trial has developed antibodies...will be used by ID Biomedical to approach Health...of four proteins. ID Biomedical is a biotechnology...
- ID Biomedical announces strong nasal immune responses in FluINsure(TM) clinical...
- Press release article from: PR Newswire July 8, 2002 700+ words
...FirstCall/ - ID Biomedical Corporation...s Phase I Clinical Trial of FluINsure...Affairs for ID Biomedical, said, "With...Data from the clinical trial will be presented...profile. About ID Biomedical ID Biomedical...
- ID Biomedical announces the beginning of a U.S. phase I clinical trial for...
- Press release article from: PR Newswire January 10, 2005 700+ words
ID Biomedical Corporation...beginning of a phase I clinical trial for a recombinant...DVC LLC, with ID Biomedical serving as the...initiation of this clinical trial. This project...Biodefense of ID Biomedical. About Plague...
Source: HighBeam Research, Vaccine Against Group A Strep Infections Approved For Phase I/II...